• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA199b-5p 的差异表达可作为散发性和遗传性甲状旁腺肿瘤的新型生物标志物。

Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors.

机构信息

Department of Internal Medicine, CHA University School of Medicine, Chaum Life Center, Seoul, Korea.

Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Sci Rep. 2018 Aug 13;8(1):12016. doi: 10.1038/s41598-018-30484-9.

DOI:10.1038/s41598-018-30484-9
PMID:30104706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6089933/
Abstract

MicroRNAs (miRNAs) are dysregulated in many tumors; however, miRNA regulation in parathyroid tumors remains poorly understood. To identify differentially expressed miRNAs between sporadic and hereditary parathyroid tumors and to analyze their correlation with clinicopathological features, a microarray containing 887 miRNAs was performed; then, the differentially expressed miRNAs were validated by qRT-PCR using 25 sporadic and 12 hereditary parathyroid tumors and 24 normal parathyroid tissue samples. A receiver operating characteristic curve (ROC) analysis was applied to evaluate the utility of the miRNAs for distinguishing parathyroid tumor types. Compared to the miRNAs in the normal parathyroid tissues, 10 miRNAs were differentially expressed between the sporadic and hereditary parathyroid tumors. Seven of these miRNAs (let-7i, miR-365, miR-125a-3p, miR-125a-5p, miR-142-3p, miR-193b, and miR-199b-5p) were validated in the parathyroid tumor samples. Among these miRNAs, only miR-199b-5p was differentially expressed (P < 0.001); miR-199b-5p was significantly downregulated and negatively associated with PTH levels (γ = -0.579, P = 0.002) in the sporadic tumors but was upregulated in the hereditary tumors. This miRNA showed 67% sensitivity and 100% specificity for distinguishing sporadic and hereditary parathyroid tumors. These results reveal altered expression of a miRNA between sporadic and hereditary parathyroid tumors and the potential role of miR-199b-5p as a novel biomarker for distinguishing these two types of parathyroid tumors.

摘要

微小 RNA(miRNAs)在许多肿瘤中失调;然而,甲状旁腺肿瘤中的 miRNA 调节仍知之甚少。为了鉴定散发性和遗传性甲状旁腺肿瘤之间差异表达的 miRNAs,并分析它们与临床病理特征的相关性,进行了包含 887 个 miRNAs 的微阵列分析;然后,使用 25 个散发性和 12 个遗传性甲状旁腺肿瘤以及 24 个正常甲状旁腺组织样本通过 qRT-PCR 验证差异表达的 miRNAs。应用接受者操作特征曲线(ROC)分析评估 miRNA 区分甲状旁腺肿瘤类型的效用。与正常甲状旁腺组织中的 miRNAs 相比,10 个 miRNAs 在散发性和遗传性甲状旁腺肿瘤之间差异表达。这 10 个 miRNAs 中的 7 个(let-7i、miR-365、miR-125a-3p、miR-125a-5p、miR-142-3p、miR-193b 和 miR-199b-5p)在甲状旁腺肿瘤样本中得到验证。在这些 miRNAs 中,只有 miR-199b-5p 差异表达(P < 0.001);miR-199b-5p 在散发性肿瘤中显著下调且与 PTH 水平呈负相关(γ=-0.579,P=0.002),而在遗传性肿瘤中上调。该 miRNA 对区分散发性和遗传性甲状旁腺肿瘤的敏感性为 67%,特异性为 100%。这些结果揭示了散发性和遗传性甲状旁腺肿瘤之间 miRNA 的表达改变,以及 miR-199b-5p 作为区分这两种类型甲状旁腺肿瘤的新型生物标志物的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe8/6089933/4f3b6f83039d/41598_2018_30484_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe8/6089933/8798e401923c/41598_2018_30484_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe8/6089933/4e06d5c8b353/41598_2018_30484_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe8/6089933/4f3b6f83039d/41598_2018_30484_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe8/6089933/8798e401923c/41598_2018_30484_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe8/6089933/4e06d5c8b353/41598_2018_30484_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe8/6089933/4f3b6f83039d/41598_2018_30484_Fig4_HTML.jpg

相似文献

1
Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors.miRNA199b-5p 的差异表达可作为散发性和遗传性甲状旁腺肿瘤的新型生物标志物。
Sci Rep. 2018 Aug 13;8(1):12016. doi: 10.1038/s41598-018-30484-9.
2
Identification of differentially expressed microRNA in parathyroid tumors.甲状旁腺肿瘤中差异表达 microRNA 的鉴定。
Ann Surg Oncol. 2011 Apr;18(4):1158-65. doi: 10.1245/s10434-010-1359-7. Epub 2010 Nov 18.
3
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.作为肺癌早期诊断潜在生物标志物的微小RNA差异表达谱
Oncol Rep. 2017 Jun;37(6):3543-3553. doi: 10.3892/or.2017.5612. Epub 2017 Apr 28.
4
Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients.差异表达的miR-3680-5p与腹膜透析患者甲状旁腺激素调节相关。
PLoS One. 2017 Feb 2;12(2):e0170535. doi: 10.1371/journal.pone.0170535. eCollection 2017.
5
Verification of candidate microRNA markers for parathyroid carcinoma.甲状旁腺癌候选微小 RNA 标志物的验证。
Endocrine. 2018 May;60(2):246-254. doi: 10.1007/s12020-018-1551-2. Epub 2018 Feb 16.
6
Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.微小RNA的微阵列表达谱分析揭示了肝细胞癌的潜在生物标志物。
Tohoku J Exp Med. 2018 Jun;245(2):89-98. doi: 10.1620/tjem.245.89.
7
Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.血浆 miRNAs 在胰腺癌的诊断和预后中的作用:一项 miRNA 表达分析。
Gene. 2018 Oct 5;673:181-193. doi: 10.1016/j.gene.2018.06.037. Epub 2018 Jun 18.
8
Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.血浆 microRNAs 作为早期胃癌早期检测的潜在新型生物标志物。
World J Gastroenterol. 2019 Apr 7;25(13):1580-1591. doi: 10.3748/wjg.v25.i13.1580.
9
Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.登革热感染患者血清微小RNA谱失调及潜在生物标志物
Int J Med Sci. 2016 Feb 18;13(3):195-205. doi: 10.7150/ijms.13996. eCollection 2016.
10
MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.miRNA 谱分析揭示骨化性纤维瘤中失调的 microRNAs 及其靶基因调控网络。
J Oral Pathol Med. 2018 Jan;47(1):78-85. doi: 10.1111/jop.12650. Epub 2017 Nov 1.

引用本文的文献

1
Serums miR-24-3p and miR-1301-3p as Potential Biomarkers in MEN1 Syndrome.血清miR-24-3p和miR-1301-3p作为MEN1综合征的潜在生物标志物
Int J Mol Sci. 2025 May 24;26(11):5076. doi: 10.3390/ijms26115076.
2
[Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].[基因确诊的1型多发性内分泌腺瘤综合征患者及其表型模拟者的血浆微小RNA表达]
Probl Endokrinol (Mosk). 2024 Jan 24;69(6):70-85. doi: 10.14341/probl13357.
3
Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation.

本文引用的文献

1
Verification of candidate microRNA markers for parathyroid carcinoma.甲状旁腺癌候选微小 RNA 标志物的验证。
Endocrine. 2018 May;60(2):246-254. doi: 10.1007/s12020-018-1551-2. Epub 2018 Feb 16.
2
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.miRTarBase 更新 2018:一个经过实验验证的 microRNA-靶标相互作用的资源库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302. doi: 10.1093/nar/gkx1067.
3
MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
胰腺神经内分泌肿瘤:信号通路与表观遗传调控
Int J Mol Sci. 2024 Jan 22;25(2):1331. doi: 10.3390/ijms25021331.
4
MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives.甲状旁腺癌中的微小RNA谱改变:最新进展与展望
Cancers (Basel). 2022 Feb 10;14(4):876. doi: 10.3390/cancers14040876.
5
Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?非编码 RNA 作为甲状旁腺肿瘤发生的有用生物标志物?
Int J Mol Sci. 2021 Sep 28;22(19):10465. doi: 10.3390/ijms221910465.
6
MicroRNA‑199a/b‑5p inhibits endometrial cancer cell metastasis and invasion by targeting in the epithelial‑to‑mesenchymal transition signaling pathway.微小 RNA-199a/b-5p 通过靶向上皮-间充质转化信号通路中的 抑制子宫内膜癌细胞的转移和侵袭。
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.11943. Epub 2021 Mar 2.
7
Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.多发性内分泌腺瘤病 1 型:微小 RNA 在该综合征治疗中的潜在作用。
Int J Mol Sci. 2020 Oct 14;21(20):7592. doi: 10.3390/ijms21207592.
8
Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.血清 microRNA 作为根治性手术后胆道癌复发和预后的预测标志物的实用性。
Sci Rep. 2019 Apr 11;9(1):5925. doi: 10.1038/s41598-019-42392-7.
MEN1基因突变以及潜在靶向MEN1的微小RNA(miRNA)是散发性和MEN1综合征相关原发性甲状旁腺功能亢进症中menin缺乏的原因。
Virchows Arch. 2017 Sep;471(3):401-411. doi: 10.1007/s00428-017-2158-3. Epub 2017 Jun 8.
4
Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas.MEN1型甲状旁腺腺瘤中差异表达的微小RNA分析
Am J Transl Res. 2017 Apr 15;9(4):1743-1753. eCollection 2017.
5
Expression levels of microRNA-199 and hypoxia-inducible factor-1 alpha in brain tissue of patients with intractable epilepsy.难治性癫痫患者脑组织中微小RNA-199和缺氧诱导因子-1α的表达水平
Int J Neurosci. 2016;126(4):326-34. doi: 10.3109/00207454.2014.994209. Epub 2015 Sep 30.
6
Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.微小RNA在甲状腺乳头状癌中的表达谱及临床意义
Molecules. 2014 Aug 5;19(8):11586-99. doi: 10.3390/molecules190811586.
7
miRWalk database for miRNA-target interactions.用于miRNA-靶标相互作用的miRWalk数据库。
Methods Mol Biol. 2014;1182:289-305. doi: 10.1007/978-1-4939-1062-5_25.
8
Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer.沉默信息调节因子 2 相关酶在肿瘤发生中的新作用:衰老与癌症之间的可能联系。
BMB Rep. 2013 Sep;46(9):429-38. doi: 10.5483/bmbrep.2013.46.9.180.
9
MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.微小 RNA-199b-5p 参与骨肉瘤中的 Notch 信号通路。
Hum Pathol. 2013 Aug;44(8):1648-55. doi: 10.1016/j.humpath.2013.01.016. Epub 2013 Apr 8.
10
Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up.散发性与 MEN 相关原发性甲状旁腺功能亢进症的区别;临床表现、术前检查、手术策略和随访。
Orphanet J Rare Dis. 2013 Apr 1;8:50. doi: 10.1186/1750-1172-8-50.